ClinicalTrials.gov
ClinicalTrials.gov Menu

Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+ (TAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01220076
Recruitment Status : Recruiting
First Posted : October 13, 2010
Last Update Posted : August 31, 2016
Sponsor:
Information provided by (Responsible Party):
Institut Cancerologie de l'Ouest

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : September 2016
  Estimated Study Completion Date : November 2016